How to evaluate a peptide headline before you share it
A fast checklist for separating useful research news from overconfident health marketing.
Educational information only — not medical advice. This page does not diagnose conditions, recommend treatment, or replace care from a qualified clinician. The Peptide Center uses an evidence-first editorial process: regulatory sources, trial registries, and peer-reviewed research take priority; uncertainty is stated rather than filled with promises.
Before sharing a peptide headline, find the original source. Is it a peer-reviewed paper, a study registry, a regulator communication, or a vendor summary? Then ask what was studied, in whom, against what comparator, for how long, and with which outcome.
References
- Therapeutic peptides: recent advances in discovery, synthesis, and clinical applications. Signal Transduction and Targeted Therapy, 2022
- ClinicalTrials.gov: Learn about studies
- Cochrane: What are systematic reviews?
Related resources
Continue with curated, same-topic resources from the published library. These links are educational references, not treatment recommendations.
5-Amino-1MQ
An evidence-first reference for reading claims and source material about 5-Amino-1MQ.
Open resourcePeptide brief5-Amino-1MQ / SLU-PP-332
An evidence-first reference for reading claims and source material about 5-Amino-1MQ / SLU-PP-332.
Open resourcePeptide briefAlpha-Klotho mAb
An evidence-first reference for reading claims and source material about Alpha-Klotho mAb.
Open resourcePeptide briefAOD-9604
An evidence-first reference for reading claims and source material about AOD-9604.
Open resourcePeptide briefAOD-9604: interpreting a fragment-peptide claim
A framework for evaluating evidence and regulatory claims around an hGH-fragment research compound.
Open resourcePeptide briefARA-290
An evidence-first reference for reading claims and source material about ARA-290.
Open resourceArticleFDA approved, compounded, and unapproved are not synonyms
A plain-language map of product categories that are often blurred in peptide discussions.
Open resourceArticleHow to read a peptide study without overclaiming
A practical guide to research stage, controls, endpoints, uncertainty, and applicability.
Open resource